Search by Drug Name or NDC
NDC 72426-0118-03 Nexletol 180 mg/1 Details
Nexletol 180 mg/1
Nexletol is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Esperion Therapeutics, Inc.. The primary component is BEMPEDOIC ACID.
MedlinePlus Drug Summary
Bempedoic acid is used together with lifestyle changes (diet, weight-loss, exercise) and certain cholesterol-lowering medications (HMG-CoA reductase inhibitors [statins]) to further decrease low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood of adults with familial heterozygous hypercholesterolemia (HeFH; an inherited condition in which cholesterol cannot be removed from the body normally) or heart disease. Bempedoic acid is in a class of medications called adenosine triphosphate-citrate lyase (ACL) inhibitors. It works by blocking the production of cholesterol in the liver.
Related Packages: 72426-0118-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bempedoic Acid
Product Information
| NDC | 72426-0118 |
|---|---|
| Product ID | 72426-118_77158886-4ee6-4972-b622-4b471e179172 |
| Associated GPIs | 39380020000320 |
| GCN Sequence Number | 080782 |
| GCN Sequence Number Description | bempedoic acid TABLET 180 MG ORAL |
| HIC3 | M4V |
| HIC3 Description | ANTIHYPERLIPIDEMIC - ATP CITRATE LYASE INHIBITOR |
| GCN | 47755 |
| HICL Sequence Number | 046382 |
| HICL Sequence Number Description | BEMPEDOIC ACID |
| Brand/Generic | Brand |
| Proprietary Name | Nexletol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bempedoic Acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 180 |
| Active Ingredient Units | mg/1 |
| Substance Name | BEMPEDOIC ACID |
| Labeler Name | Esperion Therapeutics, Inc. |
| Pharmaceutical Class | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211616 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72426-0118-03 (72426011803)
| NDC Package Code | 72426-118-03 |
|---|---|
| Billing NDC | 72426011803 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-118-03) |
| Marketing Start Date | 2020-03-06 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 13.0407 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | NEXLETOL 180 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |